mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
0.0001 |
mRNA |
JW-480 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
Vorinostat |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0003 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0003 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |